Conduction System Disease Recast as Preventive Therapy Target

New analysis of a 2015 study shows a link between intensive BP control and risk for new LV conduction disease, suggesting the conduction system could be seen 'as something we should protect.'

Related Keywords

University Of California San Francisco ,California ,United States ,Denmark ,Copenhagen ,Køavn ,San Francisco ,Johnl Sapp ,Emilie Frimodt ,University Of Copenhagen ,Varian Medical Systems ,National Institutes Of Health ,Heart Rhythm Society ,Medtronic ,Johnson ,Queen Elizabeth Ii Health Sciences Centre ,Katrine Emilie Frimodt M ,California San Francisco ,Queen Elizabeth ,Sciences Centre ,Nova Scotia ,National Institutes ,Incarda Therapeutics ,Rhythm Society ,Breaking Clinical Trials ,Hypertension ,Increased Blood Pressure ,Chronic Renal Failure ,Hronic Kidney Failure ,Hronic Kidney Disease Ckd ,Chronic Kidney Disease ,Kd ,Renal Failure ,Enal Insufficiency ,Idney Insufficiency ,Kidney Failure ,Heart Failure ,Stress ,Atrioventricular Block ,Kav Block ,Endomyocardial Fibrosis ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical ,